October 30, 2009 / 5:06 AM / 10 years ago

TABLE-Takeda Pharma <4502.T>-6mth group results

   Oct 30 (Reuters) -
                TAKEDA PHARMACEUTICAL CO. LTD.
                CONSOLIDATED FINANCIAL HIGHLIGHTS
 (in billions of yen unless specified)
            6 months ended  6 months ended  Full year to    Full year ended
               Sep 30, 2009    Sep 30, 2008    Mar 31, 2010    Mar 31, 2009
               LATEST          YEAR-AGO        COMPANY         YEAR-AGO  
               H1 RESULTS      H1 RESULTS      FORECAST        RESULTS   
 Sales             755.45          807.14            1.48 trln              
                 (-6.4 pct)                         (-3.8%)              
 Operating         242.53           85.03          395.00                   
               (+185.2 pct)                        (+28.9%)              
 Recurring         254.91          100.98          400.00                   
               (+152.4 pct)                        (+22.2%)              
 Net               189.63           71.79          280.00                   
               (+164.2 pct)                        (+19.5%)              
 EPS                  Y240.24          Y87.33         Y354.72               
 Diluted   
  EPS                 Y240.21          Y87.33                               
 Annual div                                           Y180.00         Y180.00
  -Q2 div              Y90.00          Y88.00                               
  -Q4 div                              Y92.00          Y90.00               
 NOTE - Takeda Pharmaceutical Co. Ltd. is a top-ranked drug maker. Known for
vitamin pill Alinamin.
 For latest earnings estimates made by Toyo Keizai, please
double click on 4502.TK1.

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below